Company intelligence / Profile preview

biosyn Corporation

Carlsbad, California, USAbiosyn.com ↗

Ownership: Private
Development stage: Commercial

Overview

Biosyn’s hemocyanin products have been used in over a hundred clinical trials worldwide, serving as carrier proteins or immunological tracers. Its selenase® product is registered and marketed internationally, with ongoing regulatory filings to expand its use[4][5].

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Glycoproteins (Keyhole Limpet Hemocyanin, KLH)Trace elements (Selenium products)
Industry: Contract Manufacturing Organization

Drug pipeline

2 assets

selenase

Commercial

Indications: Sepsis, Selenium deficiency, Thyroid diseases

1 more asset in the full pipeline.

Request access →

Partnerships

At least three of the ten largest international pharmaceutical companies use biosyn’s hemocyanin products for R&D of novel vaccines[4].

Beyond the preview

Go deeper on biosyn Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on biosyn Corporation.

Explore the full profile